There are currently 298 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are California, Texas, New York and Florida.
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
NCT05371756
Recruiting
The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA approved immunotherapeutics across the largest not-for-profit health system in Texas. Comprehensive clinical and radiological data from a diverse population of patients with different racial, social and eth... Read More
Gender:
All
Ages:
All
Trial Updated:
05/11/2022
Locations: Baylor Scott & White Research Institute, Dallas, Texas
Conditions: Cancer
Register for Updates
Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients
NCT03757182
Recruiting
The purpose of this study is to examine the relationships between objectively measured physical activity and provider-assessed and patient-reported functional outcomes in patients with advanced cancer. Findings from this study will help us better understand how change in daily physical activity, as measured using the wearable activity monitor, is related to change in a patient's functional status and clinical condition.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/30/2022
Locations: Cedars-Sinai Medical Center, Los Angeles, California
Conditions: Cancer, Cancer, Metastatic, Neoplasms
Register for Updates
Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant
NCT03415139
Recruiting
This clinical research studies the physiology and immunology of new-onset post-transplant diabetes mellitus in patients undergoing allogeneic stem cell transplantation. Oral glucose tolerance tests (OGTT), hyperglycemic clamps, and immune assays will be used to define the mechanisms associated with abnormal glucose homeostasis following stem cell transplantation. Information from this clinical trial could be used to develop standardized screening procedures or to develop optimal treatment strate... Read More
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
03/10/2022
Locations: Vanderbilt University Medical Center, Nashville, Tennessee
Conditions: Diabetes Mellitus, Cancer
Register for Updates
Calibration of MR and PET-MR Imaging Protocols at RIC
NCT02249520
Recruiting
This is a protocol to facilitate on-site calibration of the technical aspects of the Siemens Biograph mMR (molecular MR) Positron Emission Tomography-Magnetic Resonance (PET-MR) scanner and the 3T Siemens Vida MR scanner at the Cedars-Sinai Medical Center (CSMC) Biomedical Imaging Research Institute (BIRI) Research Imaging Core after scanner installation. The mMR is a FDA-approved standard clinical device (non-experimental) and will be used in accordance with clearance and approval from the FDA.... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/07/2022
Locations: Cedars-Sinai Medical Center, Los Angeles, California
Conditions: Cancer, Coronary Artery Disease
Register for Updates
Care Transition Intervention for Hospitalized Patients With Advanced Cancer
NCT05142345
Recruiting
This study is examining whether a care transition intervention, CONTINUUM (CONTINUity of care Under Management by video visits), consisting of a supportive care-focused video visit with an oncology nurse practitioner (NP) within three business days of hospital discharge, may improve post-discharge transitions of care for recently hospitalized patients with advanced cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/10/2022
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Conditions: Cancer, Follow-Up Care, Consultation, Remote, Advanced Cancer
Register for Updates
Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies
NCT04640246
Recruiting
This is a study of treatment with TBX-3400 in subjects with solid malignant tumors that are resistant or refractory to standard therapies. The subject's own blood cells are exposed to a protein that has been shown in the laboratory to result in anti-tumor activity. The study hypothesis is that TBX-3400 cells will enhance anti-tumor activity and improve the body's immune response to the tumor.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/01/2022
Locations: The Angeles Clinic and Research Institute, Los Angeles, California +1 locations
Conditions: Cancer, Tumor, Solid, Refractory Cancer
Register for Updates
A Crowd Sourcing Platform for Patients With Cancer
NCT03530826
Recruiting
All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/19/2021
Locations: All4Cure, Seattle, Washington
Conditions: Cancer
Register for Updates
Study of Personalized Cancer Therapy to Determine Response and Toxicity
NCT02478931
Recruiting
The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor. Optional research tests may be performed on tissue, body cavity fluid, blo... Read More
Gender:
All
Ages:
7 years and above
Trial Updated:
04/01/2021
Locations: UCSD Moores Cancer Center, La Jolla, California +2 locations
Conditions: Cancer
Register for Updates
Morehouse Total Cancer Care Protocol
NCT04804878
Recruiting
The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and "personalized medicine" for our community oncology partners (i.e., community hospital systems, and other cancer care providers). To bring new translational research to the community, Morehouse School of Medicine has initiated the Total Cancer Care Program (TCCP). The TCCP establishes a... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/16/2021
Locations: Morehouse School of Medicine, Atlanta, Georgia
Conditions: Cancer, Cancer Risk
Register for Updates
Caris Biorepository Research Protocol
NCT01499394
Recruiting
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/21/2020
Locations: Phoebe Putney Memorial Hospital, Albany, Georgia +6 locations
Conditions: Cancer
Register for Updates